azathioprine has been researched along with Coronary Disease in 50 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with azathioprine or mycophenolate did not affect PV or PI in either the SRL group (PV: 0." | 2.73 | Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation. ( Bae, JH; Clavell, AL; Edwards, BS; Frantz, RP; Khalpey, Z; Kremers, WK; Kushwaha, SS; Lerman, A; Raichlin, E; Rihal, C; Rodeheffer, RJ, 2007) |
| "Everolimus was more efficacious than azathioprine in reducing the severity and incidence of cardiac-allograft vasculopathy, suggesting that everolimus therapy may alleviate this serious problem." | 2.71 | Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. ( Abeywickrama, KH; Bernhardt, P; Dorent, R; Eisen, HJ; Hummel, M; Kobashigawa, J; Lind, JM; Mancini, D; Starling, RC; Sørensen, K; Tuzcu, EM; Valantine-von Kaeppler, HA, 2003) |
| "Graft coronary disease was found in 8 patients (11%), 2 were re-transplanted and have survived 4." | 1.33 | Ten year survival after paediatric heart transplantation: a single centre experience. ( Khaghani, A; Smith, RR; Wray, J; Yacoub, M, 2005) |
| "Coronary heart disease was also more frequent in PTDM (15 vs." | 1.31 | High incidence of post-transplant diabetes mellitus in Kuwait. ( Al-Mousawi, M; Costandi, JN; Gupta, RK; Johny, KV; Muzairai, I; Nampoory, MR; Ninan, VT; Samhan, M, 2002) |
| "Hypertension is a common concomitant condition in renal transplant recipients." | 1.30 | Hypertension is associated with hyperlipidemia, coronary heart disease and chronic graft failure in kidney transplant recipients. ( Bölscher, S; Geiger, H; Kachel, HG; Lenz, T; Peschke, B; Scheuermann, EH, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (42.00) | 18.7374 |
| 1990's | 13 (26.00) | 18.2507 |
| 2000's | 16 (32.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| John, R | 1 |
| Lietz, K | 1 |
| Schuster, M | 1 |
| Naka, Y | 1 |
| Rao, V | 1 |
| Mancini, DM | 1 |
| Rose, EA | 3 |
| Smith, CR | 2 |
| Oz, MC | 1 |
| Edwards, NM | 1 |
| Itescu, S | 1 |
| Tedesco Silva, H | 1 |
| Felipe, CR | 1 |
| Machado, PG | 1 |
| Garcia, R | 1 |
| Motegi, S | 1 |
| Hosaka, BH | 1 |
| Hanzawa, NM | 1 |
| Park, SI | 1 |
| Casarini, D | 1 |
| Lima, VC | 1 |
| Franco, M | 1 |
| Medina-Pestana, JO | 1 |
| Avery, RK | 1 |
| Eisen, HJ | 1 |
| Tuzcu, EM | 1 |
| Dorent, R | 1 |
| Kobashigawa, J | 1 |
| Mancini, D | 1 |
| Valantine-von Kaeppler, HA | 1 |
| Starling, RC | 1 |
| Sørensen, K | 1 |
| Hummel, M | 1 |
| Lind, JM | 1 |
| Abeywickrama, KH | 1 |
| Bernhardt, P | 1 |
| Banas, B | 1 |
| Böger, C | 1 |
| Krämer, B | 1 |
| El-Sayed, O | 1 |
| Magorien, RD | 1 |
| Orsini, A | 1 |
| Ferketich, AK | 1 |
| Leier, CV | 1 |
| Valantine, H | 2 |
| Smith, RR | 1 |
| Wray, J | 1 |
| Khaghani, A | 3 |
| Yacoub, M | 2 |
| Li, HY | 1 |
| Tanaka, K | 1 |
| Oeser, B | 1 |
| Wertman, B | 1 |
| Kobashigawa, JA | 1 |
| Tobis, JM | 1 |
| Kaczmarek, I | 1 |
| Ertl, B | 1 |
| Schmauss, D | 1 |
| Sadoni, S | 1 |
| Knez, A | 1 |
| Daebritz, S | 1 |
| Meiser, B | 1 |
| Reichart, B | 2 |
| Raichlin, E | 1 |
| Bae, JH | 1 |
| Khalpey, Z | 1 |
| Edwards, BS | 1 |
| Kremers, WK | 1 |
| Clavell, AL | 1 |
| Rodeheffer, RJ | 1 |
| Frantz, RP | 1 |
| Rihal, C | 1 |
| Lerman, A | 1 |
| Kushwaha, SS | 1 |
| Mudge, GH | 1 |
| Annemans, L | 1 |
| Lemkuhl, H | 1 |
| Tenderich, G | 1 |
| Schulz, U | 1 |
| Yang, XL | 1 |
| Ricci, JF | 1 |
| Hetzer, R | 2 |
| Hosenpud, JD | 1 |
| Montanaro, A | 1 |
| Hart, MV | 1 |
| Haines, JE | 1 |
| Specht, HD | 1 |
| Bennett, RM | 1 |
| Kloster, FE | 1 |
| Chrétien, J | 1 |
| Hunt, S | 1 |
| Gamberg, P | 1 |
| Miller, J | 1 |
| Luikart, H | 1 |
| Wahlers, T | 1 |
| Mügge, A | 1 |
| Oppelt, P | 1 |
| Heublein, B | 1 |
| Fieguth, HG | 1 |
| Jurmann, M | 1 |
| Haverich, A | 1 |
| Addonizio, LJ | 1 |
| Hsu, DT | 1 |
| Douglas, JF | 1 |
| Kichuk, MR | 1 |
| Michler, RE | 1 |
| Quaegebeur, JM | 1 |
| Stapleton, DD | 1 |
| Ventura, HO | 1 |
| Grundtner, SE | 1 |
| Smart, FW | 1 |
| Price, HL | 1 |
| Van Meter, C | 1 |
| Ochsner, JL | 1 |
| Pham, SM | 1 |
| Kormos, RL | 1 |
| Kawai, A | 1 |
| Murali, S | 1 |
| Hattler, BG | 1 |
| Demetris, AJ | 1 |
| Griffith, BP | 1 |
| Gajarski, RJ | 1 |
| Smith, EO | 1 |
| Denfield, SW | 1 |
| Rosenblatt, HM | 1 |
| Kearney, D | 1 |
| Frazier, OH | 1 |
| Radovancevic, B | 1 |
| Price, JK | 1 |
| Kertesz, NJ | 1 |
| Towbin, JA | 1 |
| Peddi, VR | 1 |
| Whiting, J | 1 |
| Weiskittel, PD | 1 |
| Alexander, JW | 1 |
| First, MR | 1 |
| Frustaci, A | 2 |
| Chimenti, C | 2 |
| Maseri, A | 2 |
| Pieroni, M | 1 |
| Peschke, B | 1 |
| Scheuermann, EH | 1 |
| Geiger, H | 1 |
| Bölscher, S | 1 |
| Kachel, HG | 1 |
| Lenz, T | 1 |
| Sánchez, V | 1 |
| Delgado, JF | 1 |
| Blasco, T | 1 |
| Dalmau, R | 1 |
| Morales, JM | 1 |
| Escribano, P | 1 |
| Tello, R | 1 |
| Hernández, J | 1 |
| Velázquez, T | 1 |
| Sotelo, T | 1 |
| Gómez-Sánchez, MA | 1 |
| Sáenz de la Calzada, C | 1 |
| Barr, ML | 1 |
| Baker, CJ | 1 |
| Schenkel, FA | 1 |
| McLaughlin, SN | 1 |
| Stouch, BC | 1 |
| Starnes, VA | 1 |
| Johny, KV | 1 |
| Nampoory, MR | 1 |
| Costandi, JN | 1 |
| Gupta, RK | 1 |
| Ninan, VT | 1 |
| Samhan, M | 1 |
| Muzairai, I | 1 |
| Al-Mousawi, M | 1 |
| Hennersdorf, F | 1 |
| Wellnhofer, E | 1 |
| Musci, M | 1 |
| Bocksch, W | 1 |
| Spiegelsberger, S | 1 |
| Heins, S | 1 |
| Fleck, E | 1 |
| Schroeder, JS | 3 |
| Rider, AK | 2 |
| Stinson, EB | 5 |
| Shumway, NE | 3 |
| Barnard, CN | 1 |
| Delmonico, FL | 1 |
| Cosimi, AB | 1 |
| Russell, PS | 1 |
| Barbir, M | 1 |
| Banner, N | 1 |
| Thompson, GR | 1 |
| Mitchell, A | 1 |
| Olivari, MT | 2 |
| Kubo, SH | 2 |
| Braunlin, EA | 1 |
| Bolman, RM | 1 |
| Ring, WS | 2 |
| Aravot, DJ | 1 |
| Banner, NR | 1 |
| Fitzgerald, M | 1 |
| Radley-Smith, R | 1 |
| Mitchell, AG | 1 |
| Yacoub, MH | 1 |
| Gao, SZ | 1 |
| Alderman, EL | 1 |
| Hunt, SA | 1 |
| Valantine, HA | 1 |
| Wiederhold, V | 1 |
| Homans, DC | 1 |
| Wilson, RF | 1 |
| Becerra, E | 1 |
| Cooper, DK | 1 |
| Novitzky, D | 1 |
| Baumgartner, WA | 1 |
| Augustine, S | 1 |
| Borkon, AM | 1 |
| Gardner, TJ | 1 |
| Reitz, BA | 1 |
| Hess, ML | 1 |
| Hastillo, A | 1 |
| Thompson, JA | 1 |
| Sansonetti, DJ | 1 |
| Szentpetery, S | 1 |
| Barnhart, G | 1 |
| Lower, RR | 2 |
| Jordan, ML | 1 |
| Novick, AC | 1 |
| Steinmuller, D | 1 |
| Braun, W | 1 |
| Buszta, C | 1 |
| Mintz, D | 1 |
| Goormastic, M | 1 |
| Streem, S | 1 |
| Laden, AM | 1 |
| Ruszkiewicz, M | 1 |
| Graham, AF | 1 |
| Caves, PK | 1 |
| Harrison, DC | 1 |
| Hollander, CF | 1 |
| Cooley, DA | 1 |
| Messmer, BJ | 1 |
| Hallman, GL | 1 |
| Bloodwell, RD | 1 |
| Nora, JJ | 1 |
| Leachman, RD | 1 |
| Goldstein, HM | 1 |
| Castellino, RA | 1 |
| Wexler, L | 1 |
| Dong, E | 1 |
| Bieber, CP | 1 |
| Popp, RL | 1 |
| Chatty, ME | 1 |
| Deodhar, SD | 1 |
| Dubost, C | 1 |
| Cachera, JP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prophylaxis of the Graft-Versus-Host-Disease in Patients After Allogeneic Stem Cell Transplantation With a Combination of Tacrolimus and Everolimus[NCT00117702] | Phase 2/Phase 3 | 24 participants (Actual) | Interventional | 2005-10-31 | Terminated (stopped due to safety reasons) | ||
| Safety and Efficacy of Low-dose Cyclosporine in Association With Everolimus to Minimize Renal Dysfunction in Heart Transplant Recipients[NCT00420537] | Phase 4 | 34 participants (Actual) | Interventional | 2006-09-30 | Terminated (stopped due to A cluster of adverse events in everolimus arm was noted.) | ||
| A Phase II Trial of RAD001 in Triple Negative Metastatic Breast Cancer[NCT00827567] | Phase 2 | 6 participants (Actual) | Interventional | 2009-04-30 | Terminated (stopped due to Slow accrual) | ||
| A Randomized Prospective Trial of Conversion to Everolimus Therapy From Calcineurin Inhibitor Based Maintenance Immunosuppression in Association With Mycophenolic Acid in Liver Transplantation: Examination of Impact on Long Term Renal Function.[NCT01936519] | 24 participants (Actual) | Interventional | 2013-12-16 | Completed | |||
| Early Vs Late Sirolimus-Initiation Strategies To Prevent Cardiac Allograft Vasculopathy Related Events in Heart Transplant Recipients[NCT01305395] | 0 participants (Actual) | Interventional | 2010-11-30 | Withdrawn (stopped due to Due in part, to reduced transplant volume and enrollment has been difficult.) | |||
| Cardiac Allograft Remodeling and Effects of Sirolimus on Its Progression[NCT01889992] | Phase 1 | 42 participants (Actual) | Interventional | 2013-04-24 | Terminated (stopped due to PI left University and project not continued) | ||
| Impact of Photopheresis in the Prevention of Acute Rejection in Highly Sensitized de Novo Kidney Transplant Recipients[NCT04414735] | 30 participants (Anticipated) | Interventional | 2022-08-17 | Recruiting | |||
| The Use of Extracorporeal Photopheresis as Immunomodulatory Therapy of Subclinical Antibody-mediated Rejection After Lung Transplantation: a Prospective RCT[NCT06112951] | 80 participants (Anticipated) | Interventional | 2023-11-01 | Not yet recruiting | |||
| Prospective, Observational Trial of Biological or Prosthetic Mesh for Open Ventral Hernia Repair[NCT03317665] | 28 participants (Actual) | Observational | 2019-02-11 | Terminated (stopped due to Premature termination due to cease of funding) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
A blood sample was obtained from recipients and donors to measure gene polymorphism effects on metabolism of calcineurin inhibitor and everolimus. The polymorphisms are represented as the number of SNP occurrences for the CYP3A5, ABCB1 (MDR1) gene, and CYP4A4*22 genes. (NCT01936519)
Timeframe: 2 years
| Intervention | Participants (Count of Participants) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Recipient Genotypes : rs776746 (CYP3A5 gene) | Recipient Genotypes : rs1045642 (ABCB1 gene) | Recipient Genotypes : rs1128503 (ABCB1 gene) | Recipient Genotypes : rs2032582 (ABCB1 gene) | Recipient Genotypes : rs35599367 (CYP4A4*22 gene) | Donor Genotypes : rs776746 (CYP3A5 gene) | Donor Genotypes : rs1045642 (ABCB1 gene) | Donor Genotypes : rs1128503 (ABCB1 gene) | Donor Genotypes : rs2032582 (ABCB1 gene) | Donor Genotypes : rs35599367 (Cyp4A4*22) | |
| Calcineurin Inhibitor and Mycophenolic Acid | 11 | 6 | 7 | 1 | 1 | 3 | 1 | 0 | 0 | 0 |
| Everolimus and Mycophenolic Acid | 11 | 6 | 8 | 0 | 1 | 0 | 5 | 0 | 0 | 1 |
Renal Function was assessed by 24 hr urine collection creatinine clearance measured (mL/min). 24 Hr urine collection was assessed at baseline, 6 months, 1 year, and 2 years post transplant. (NCT01936519)
Timeframe: 6 months, 1 year, and 2 years
| Intervention | mL/min (Mean) | ||
|---|---|---|---|
| 24hr Urine Creatinine Clearance at 6 months | 24hr Urine Creatinine Clearance at 1 year | 24hr Urine Creatinine Clearance at 2 years | |
| Calcineurin Inhibitor With Mycophenolic Acid | 68.09 | 68.09 | 61.54 |
| Everolimus With Mycophenolic Acid | 70.75 | 86.8 | 90.63 |
The Cockcroft-Gault formula for estimating creatinine clearance was determined at 6 months, 1 year, and 2 years post transplant (NCT01936519)
Timeframe: 6 months, 1 year, and 2 years
| Intervention | mL/min/1.73m2 (Mean) | ||
|---|---|---|---|
| Cockcroft Gault Creatinine Clearance at 6 months | Cockcroft Gault Creatinine Clearance at 1 year | Cockcroft Gault Creatinine Clearance at 2 years | |
| Calcineurin Inhibitor and Mycophenolic Acid | 79.84 | 86.84 | 80.85 |
| Everolimus and Mycophenolic Acid | 100.17 | 113.47 | 108.16 |
Iothalamate Clearance was assessed at 6 months, 1 year, and 2 years post transplant. (NCT01936519)
Timeframe: 6 months, 1 year, and 2 years
| Intervention | mL/min/1.73m2 (Mean) | ||
|---|---|---|---|
| Iothalamate Clearance at 6 months | Iothalamate Clearance at 1 year | Iothalamate Clearance at 2 years | |
| Calcineurin Inhibitor and Mycophenolic Acid | 67.99 | 66.65 | 57.19 |
| Everolimus and Mycophenolic Acid | 74.23 | 104.01 | 79.41 |
Modification of Diet in Renal Disease (MDRD) estimated Glomerular Filtration Rate (eGFR) was assessed at 6 months, 1 year, and 2 years post transplant. (NCT01936519)
Timeframe: 6 months, 1 year, and 2 years
| Intervention | mL/min/1.73 m2 (Mean) | ||
|---|---|---|---|
| MDRD eGFR at 6 months | MDRD eGFR at 1 year | MDRD eGFR at 2 years | |
| Calcineurin Inhibitor and Mycophenolic Acid | 62.18 | 60.63 | 53.29 |
| Everolimus and Mycophenolic Acid | 81.27 | 88.01 | 87.37 |
Serum creatinine levels were assessed at 6 months, 1 year, and 2 years post transplant (NCT01936519)
Timeframe: 6 months, 1 year, and 2 years
| Intervention | mg/dL (Mean) | ||
|---|---|---|---|
| Serum Creatinine at 6 months | Serum Creatinine at 1 year | Serum Creatinine at 2 years | |
| Calcineurin Inhibitor and Mycophenolic Acid | 1.29 | 1.29 | 1.51 |
| Everolimus and Mycophenolic Acid | 1.02 | 0.95 | 0.95 |
1 review available for azathioprine and Coronary Disease
| Article | Year |
|---|---|
Current status of clinical cardiac transplantation.
Topics: Adult; Arteriosclerosis; Azathioprine; B-Lymphocytes; Brain Death; Cardiac Catheterization; Cardiomy | 1974 |
9 trials available for azathioprine and Coronary Disease
| Article | Year |
|---|---|
Safety and efficacy of sirolimus in kidney transplant patients and in patients with coronary artery disease undergoing angioplasty.
Topics: Adult; Angioplasty, Balloon, Coronary; Azathioprine; Black People; Cadaver; Coronary Disease; Cyclos | 2003 |
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
Topics: Adult; Aged; Azathioprine; Coronary Disease; Coronary Vessels; Cyclosporine; Cytomegalovirus Infecti | 2003 |
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
Topics: Adult; Aged; Azathioprine; Coronary Disease; Coronary Vessels; Cyclosporine; Cytomegalovirus Infecti | 2003 |
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
Topics: Adult; Aged; Azathioprine; Coronary Disease; Coronary Vessels; Cyclosporine; Cytomegalovirus Infecti | 2003 |
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
Topics: Adult; Aged; Azathioprine; Coronary Disease; Coronary Vessels; Cyclosporine; Cytomegalovirus Infecti | 2003 |
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
Topics: Adult; Aged; Azathioprine; Coronary Disease; Coronary Vessels; Cyclosporine; Cytomegalovirus Infecti | 2003 |
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
Topics: Adult; Aged; Azathioprine; Coronary Disease; Coronary Vessels; Cyclosporine; Cytomegalovirus Infecti | 2003 |
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
Topics: Adult; Aged; Azathioprine; Coronary Disease; Coronary Vessels; Cyclosporine; Cytomegalovirus Infecti | 2003 |
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
Topics: Adult; Aged; Azathioprine; Coronary Disease; Coronary Vessels; Cyclosporine; Cytomegalovirus Infecti | 2003 |
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
Topics: Adult; Aged; Azathioprine; Coronary Disease; Coronary Vessels; Cyclosporine; Cytomegalovirus Infecti | 2003 |
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
Topics: Adult; Aged; Azathioprine; Coronary Disease; Coronary Vessels; Cyclosporine; Cytomegalovirus Infecti | 2003 |
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
Topics: Adult; Aged; Azathioprine; Coronary Disease; Coronary Vessels; Cyclosporine; Cytomegalovirus Infecti | 2003 |
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
Topics: Adult; Aged; Azathioprine; Coronary Disease; Coronary Vessels; Cyclosporine; Cytomegalovirus Infecti | 2003 |
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
Topics: Adult; Aged; Azathioprine; Coronary Disease; Coronary Vessels; Cyclosporine; Cytomegalovirus Infecti | 2003 |
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
Topics: Adult; Aged; Azathioprine; Coronary Disease; Coronary Vessels; Cyclosporine; Cytomegalovirus Infecti | 2003 |
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
Topics: Adult; Aged; Azathioprine; Coronary Disease; Coronary Vessels; Cyclosporine; Cytomegalovirus Infecti | 2003 |
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
Topics: Adult; Aged; Azathioprine; Coronary Disease; Coronary Vessels; Cyclosporine; Cytomegalovirus Infecti | 2003 |
Advancing immunosuppression therapy to counter the progression of cardiac allograft vasculopathy.
Topics: Azathioprine; Coronary Angiography; Coronary Disease; Cyclosporine; Drug Therapy, Combination; Femal | 2005 |
Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation.
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Coronary Disease; Female; Heart Transplantation; | 2007 |
Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation.
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Coronary Disease; Female; Heart Transplantation; | 2007 |
Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation.
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Coronary Disease; Female; Heart Transplantation; | 2007 |
Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation.
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Coronary Disease; Female; Heart Transplantation; | 2007 |
Economic evaluation of everolimus and mycophenolate mofetil versus azathioprine in de novo heart transplantation.
Topics: Acute Disease; Adult; Azathioprine; Belgium; Cardiomyopathy, Dilated; Coronary Disease; Cost of Illn | 2007 |
Coronary vasculopathy following cardiac transplantation and cyclosporine immunosuppression: preventive treatment with angiopeptin, a somatostatin analog.
Topics: Antilymphocyte Serum; Arteriosclerosis; Azathioprine; Coronary Disease; Cyclosporine; Female; Heart | 1994 |
Induction immunosuppression with the monoclonal antibody OKT3 after cardiac transplantation.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Coronary Disease; Creatinine; Cyclosporine; Drug Thera | 1993 |
Tacrolimus (FK 506) in clinical cardiac transplantation: a five-year experience.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Communicable Diseases; Coronary Disease; Cyclosporine; Dr | 1996 |
Prophylactic photopheresis and chronic rejection: effects on graft intimal hyperplasia in cardiac transplantation.
Topics: Adolescent; Adult; Antibodies; Azathioprine; Chronic Disease; Coronary Disease; Coronary Vessels; Cy | 2000 |
Prophylactic photopheresis and chronic rejection: effects on graft intimal hyperplasia in cardiac transplantation.
Topics: Adolescent; Adult; Antibodies; Azathioprine; Chronic Disease; Coronary Disease; Coronary Vessels; Cy | 2000 |
Prophylactic photopheresis and chronic rejection: effects on graft intimal hyperplasia in cardiac transplantation.
Topics: Adolescent; Adult; Antibodies; Azathioprine; Chronic Disease; Coronary Disease; Coronary Vessels; Cy | 2000 |
Prophylactic photopheresis and chronic rejection: effects on graft intimal hyperplasia in cardiac transplantation.
Topics: Adolescent; Adult; Antibodies; Azathioprine; Chronic Disease; Coronary Disease; Coronary Vessels; Cy | 2000 |
40 other studies available for azathioprine and Coronary Disease
| Article | Year |
|---|---|
Immunologic sensitization in recipients of left ventricular assist devices.
Topics: Actuarial Analysis; Acute Disease; Aged; Anti-Inflammatory Agents; Azathioprine; Coronary Disease; C | 2003 |
Cardiac-allograft vasculopathy.
Topics: Azathioprine; Coronary Disease; Cytomegalovirus Infections; Drug Therapy, Combination; Everolimus; H | 2003 |
Everolimus in cardiac-transplant recipients.
Topics: Azathioprine; Coronary Disease; Coronary Vessels; Everolimus; Graft Rejection; Heart Transplantation | 2003 |
Prevention of cardiac allograft vasculopathy with Certican (everolimus): the Stanford University experience within the Certican Phase III clinical trial.
Topics: Adult; Angioplasty, Balloon, Coronary; Azathioprine; Clinical Trials, Phase III as Topic; Coronary D | 2005 |
Ten year survival after paediatric heart transplantation: a single centre experience.
Topics: Azathioprine; Cardiomyopathies; Child; Child, Preschool; Coronary Angiography; Coronary Disease; Cyc | 2005 |
Compensatory enlargement in transplant coronary artery disease: an intravascular ultrasound study.
Topics: Adult; Aged; Azathioprine; Coronary Disease; Coronary Vessels; Female; Heart Transplantation; Humans | 2006 |
Preventing cardiac allograft vasculopathy: long-term beneficial effects of mycophenolate mofetil.
Topics: Adolescent; Adult; Aged; Azathioprine; Coronary Disease; Disease Progression; Heart Transplantation; | 2006 |
Sirolimus and cardiac transplantation: is it the "magic bullet"?
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Coronary Disease; Female; Heart Transplantation; | 2007 |
Myocardial perfusion abnormalities in asymptomatic patients with systemic lupus erythematosus.
Topics: Adolescent; Adult; Azathioprine; Cicatrix; Coronary Disease; Exercise Test; Female; Heart; Humans; L | 1984 |
[Idiopathic fibrogenous interstitial pneumopathy].
Topics: Adrenal Cortex Hormones; Azathioprine; Coronary Disease; Humans; Lung; Lung Neoplasms; Pulmonary Fib | 1980 |
Impact of cyclosporine dose on long-term outcome after heart transplantation.
Topics: Actuarial Analysis; Antilymphocyte Serum; Azathioprine; Coronary Disease; Cyclosporine; Dose-Respons | 1994 |
Decreasing incidence of coronary disease in pediatric cardiac transplant recipients using increased immunosuppression.
Topics: Azathioprine; Child; Coronary Angiography; Coronary Disease; Cyclosporine; Follow-Up Studies; Graft | 1993 |
Long-term results of triple-drug-based immunosuppression in nonneonatal pediatric heart transplant recipients.
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Coronary Disease; Cyclosporine; Drug Thera | 1998 |
Characteristics of long-term renal transplant survivors.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Child; Child, Preschool; Coronary Disease; Female; Follow- | 1998 |
Global biventricular dysfunction in patients with asymptomatic coronary artery disease may be caused by myocarditis.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Autoimmune Diseases; Azathioprine; Biopsy; Cardiomy | 1999 |
Histologically proven myocarditis in patients with biventricular dysfunction and severe asymptomatic coronary artery disease.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Biopsy; Coronary Angiography; Coronary Disease; Echoc | 1999 |
Hypertension is associated with hyperlipidemia, coronary heart disease and chronic graft failure in kidney transplant recipients.
Topics: Azathioprine; Coronary Disease; Cyclosporine; Graft Rejection; Humans; Hyperlipidemias; Hypertension | 1999 |
Benefits of mycophenolate mofetil in cardiac transplant recipients with cyclosporine-induced nephropathy.
Topics: Azathioprine; Cardiomyopathy, Dilated; Coronary Disease; Cyclosporine; Female; Graft Rejection; Hear | 1999 |
High incidence of post-transplant diabetes mellitus in Kuwait.
Topics: Adult; Azathioprine; Cause of Death; Coronary Disease; Cyclosporine; Diabetes Mellitus; Female; Graf | 2002 |
Aspects of cyclosporine A toxicity in the development of coronary artery disease in transplant recipients.
Topics: Adult; Azathioprine; Coronary Disease; Cyclosporine; Drug Therapy, Combination; Heart Transplantatio | 2002 |
Cardiac transplantation: review of seven years' experience.
Topics: Azathioprine; Coronary Disease; Graft Rejection; Heart Transplantation; Immunosuppression Therapy; P | 1976 |
The present status of heart transplantation.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Coronary Disease; Echocardiography; Electrocardiography; | 1975 |
Renal transplantation in the older age group.
Topics: Acute Kidney Injury; Age Factors; Aged; Azathioprine; Cadaver; Coronary Disease; Diabetes Complicati | 1975 |
Relationship of immunosuppression and serum lipids to the development of coronary arterial disease in the transplanted heart.
Topics: Adult; Age Factors; Azathioprine; Cholesterol; Coronary Disease; Cyclosporins; Female; Heart Transpl | 1991 |
Five-year experience with triple-drug immunosuppressive therapy in cardiac transplantation.
Topics: Actuarial Analysis; Azathioprine; Coronary Disease; Cyclosporins; Drug Therapy, Combination; Female; | 1990 |
Cardiac transplantation in the seventh decade of life.
Topics: Actuarial Analysis; Aged; Azathioprine; Cardiomyopathy, Dilated; Coronary Disease; Cyclosporins; Fem | 1989 |
Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens.
Topics: Azathioprine; Cohort Studies; Coronary Disease; Cyclosporins; Female; Graft Rejection; Heart Transpl | 1989 |
Coronary artery disease in cardiac transplant patients receiving triple-drug immunosuppressive therapy.
Topics: Azathioprine; Coronary Disease; Cyclosporins; Female; Graft Rejection; Heart Transplantation; Histoc | 1989 |
Are there indications for heterotopic heart transplantation today?
Topics: Adolescent; Adult; Antilymphocyte Serum; Azathioprine; Cardiomyopathies; Coronary Disease; Cyclospor | 1987 |
Present expectations in cardiac transplantation.
Topics: Adolescent; Adult; Azathioprine; Cardiomyopathies; Child; Child, Preschool; Coronary Disease; Cyclos | 1987 |
Lipid mediators in organ transplantation: does cyclosporine accelerate coronary atherosclerosis?
Topics: Adolescent; Adult; Antilymphocyte Serum; Azathioprine; Child; Coronary Disease; Cyclosporins; Female | 1987 |
Renal transplantation in the older recipient.
Topics: Age Factors; Antilymphocyte Serum; Azathioprine; Cadaver; Cardiomyopathies; Coronary Disease; Diabet | 1985 |
Circulating antibody following cardiac transplantation in Ag-B-compatible rats.
Topics: Animals; Antibody Formation; Azathioprine; Chromium Isotopes; Coronary Disease; Cytotoxicity Tests, | 1972 |
Acute rejection in the long-term cardiac transplant survivor. Clinical diagnosis, treatment and significance.
Topics: Arteriosclerosis; Azathioprine; Biopsy; Coronary Disease; Cyclophosphamide; Electrocardiography; End | 1974 |
Cardiac allograft pathology in Rhesus monkeys.
Topics: Animals; Antilymphocyte Serum; Arteriosclerosis; Azathioprine; Coronary Disease; Coronary Vessels; G | 1973 |
[Heart transplantation as a possibility in severe coronary insufficiency].
Topics: Adult; Aged; Antilymphocyte Serum; Azathioprine; Coronary Disease; Female; Heart Transplantation; He | 1969 |
Roentgenologic aspects of cardiac transplantation. Postoperative pulmonary infections.
Topics: Adult; Azathioprine; Biopsy; Cardiomyopathies; Coronary Disease; Female; Heart Transplantation; Huma | 1971 |
Cardiac transplantation in man. II. Immunosuppressive therapy.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Cardiomyopathies; Coronary Disease; Dactinomycin; Female; | 1969 |
Myocardial changes and kidney transplantation. Lesions in patients receiving immunosuppressive therapy.
Topics: Adolescent; Adult; Aged; Antilymphocyte Serum; Arteriosclerosis; Autopsy; Azathioprine; Candida; Car | 1969 |
[3 cases of allogenic heart graft in man].
Topics: Adult; Angiocardiography; Azathioprine; Coronary Disease; Electrocardiography; Globulins; Heart Fail | 1969 |